Sandy Madigan work email
- Valid
- Valid
- Valid
- Valid
Sandy Madigan personal email
Sandy Madigan phone numbers
Sandy brings over 30 years of experience to roles at Avalon Bioventures and Avalon portfolio companies and has a track record of building early-stage companies, licensing technologies, providing strategic direction, and negotiating partnerships and acquisitions. Most recently, Sandy was a founder and CEO of Nerio Therapeutics (sold to Boehringer Ingelheim for $1.3B in July, 2024) and the transacting CEO of Calporta Therapeutics which (acquired by Merck for up to $576M in November, 2019).Sandy performed his post-doctoral training at The Salk Institute for Biological Studies. He received his Ph.D. in genetics and his B.S. in biochemistry from The State University of New York at Stony Brook where, as a graduate student, he was a recipient of the Abrahams Memorial Award bestowed for outstanding potential for basic research.
-
DirectorValora Therapeutics, Inc. Jul 2024 - PresentSan Diego, California, Us
-
President & CboEnlaza Therapeutics Nov 2020 - PresentSan Diego, Ca, UsEnlaza Therapeutics (www.enlazatx.com) is pioneering the field of covalent biologics. These novel classes of protein therapeutics deliver more efficacious and safer treatments for patients. The company’s proprietary War-LockTM platform leverages leading synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza is building a pipeline of first-in-class covalent biologics. -
Managing PartnerAvalon Bioventures I 2021 - PresentAvalon BioVentures is primarily focused on early-stage opportunities. We look to build value by developing companies in our Accelerator which provides management, scientific and operational support to entrepreneurs. www.avalonbioventures.com
-
CeoAnkasa Regenerative Therapeutics, Inc. Sep 2014 - PresentSouth San Francisco, California, UsAnkasa is a clinical-stage company developing strategies to improve tissue healing by exploiting the potential of stem cell re-activation. Our initial product is a proprietary formulation of recombinant human WNT protein with demonstrated superiority for bone formation. The Company is currently enrolling a clinical trial in spinal fusion procedures. The field is lacking a bona fide therapeutic agent with demonstrated superiority to standard of care. Successful development of this product will offer surgeons and patients a new opportunity for faster healing accompanied by solid fusions thereby reducing the rate of revision surgeries and their attendant complications. This is both a direct benefit to an at-risk, aging, patient population, as well as direct savings to the healthcare system. -
Chief Executive OfficerNerio Therapeutics, Inc. Mar 2019 - Jul 2024Founder and CEO Nerio Therapuetics. Acquired by Boehringer Ingelheim for up to $1.3B.
-
CeoCalporta Therapeutics 2018 - 2020Calporta was acquired by Merck in November, 2019 for up to $576M. Calporta develops selective small molecule agonists of TRPML1, which play a role in lysosomal function by promoting autophagy and lysosomal exocytosis. Calporta’s TRPML1 agonists may have broad potential to treat various lysosomal storage and neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease.
-
Ceo, Co-FounderStrategic Enzyme Applications Jan 2009 - Dec 2012
-
Vp, Corporate DevelopmentBioverdant 2006 - 2008Us -
Vp, Corporate DevelopmentNereus Pharmaceuticals 2002 - 2005Us -
Vp, Corporate DevelopmentAmbit Biosciences 2001 - 2002
-
Vp, Corporate DevelopmentX-Ceptor Therapeutics 1999 - 2001
-
Director, Business DevelopmentSibia Neurosciences 1996 - 1999
Sandy Madigan Skills
Sandy Madigan Education Details
-
Stony Brook UniversityBiochemistry -
Stony Brook UniversityGenetics
Frequently Asked Questions about Sandy Madigan
What company does Sandy Madigan work for?
Sandy Madigan works for Valora Therapeutics, Inc.
What is Sandy Madigan's role at the current company?
Sandy Madigan's current role is Partner at Avalon BioVentures.
What is Sandy Madigan's email address?
Sandy Madigan's email address is sa****@****rma.com
What is Sandy Madigan's direct phone number?
Sandy Madigan's direct phone number is (858) 750*****
What schools did Sandy Madigan attend?
Sandy Madigan attended Stony Brook University, Stony Brook University.
What skills is Sandy Madigan known for?
Sandy Madigan has skills like Biotechnology, Pharmaceutical Industry, Biochemistry, Chemistry, Strategy, Drug Development, Technology Transfer, Neuroscience, Drug Discovery, Commercialization, Biopharmaceuticals, Corporate Development.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial